Less than three years after it was established, the life sciences-focused investment firm is building out a portfolio of labs and offices to help the UK industry meet its potential. Its team talks to Evelina Grecenko about its next London
Thank you for reading EG
Want to read more? Enjoy a story a week for FREE for one month.